What to Know About Imfinzi for Non-Small-Cell Lung Cancer
If you or a loved one has lung cancer, you may be interested in learning more about medicines used to treat it. One option is an immunotherapy medicine called Imfinzi (durvalumab). Immunotherapy medicines work by helping your immune system find and attack cancer cells.The FDA approved Imfinzi in 2017. It is approved to treat non-small-cell lung cancer (NSCLC) in certain people. NSCLC is the most common type of lung cancer. Imfinzi is also FDA-approved to treat other types of cancer, including a...